Free Trial

Nukkleus (NASDAQ:NUKK) Trading 0.5% Higher - Still a Buy?

Nukkleus logo with Business Services background

Nukkleus Inc. (NASDAQ:NUKK - Get Free Report)'s stock price traded up 0.5% during trading on Wednesday . The stock traded as high as $9.75 and last traded at $9.70. 108,656 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 1,432,567 shares. The stock had previously closed at $9.65.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded Nukkleus from a "sell" rating to a "hold" rating in a report on Friday, May 30th.

Read Our Latest Research Report on NUKK

Nukkleus Stock Down 11.0%

The business's 50 day moving average is $13.51 and its 200-day moving average is $16.95.

Nukkleus (NASDAQ:NUKK - Get Free Report) last released its earnings results on Friday, May 23rd. The company reported $18.19 earnings per share for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nukkleus stock. Compagnie Lombard Odier SCmA acquired a new position in shares of Nukkleus Inc. (NASDAQ:NUKK - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 6,200 shares of the company's stock, valued at approximately $74,000. Compagnie Lombard Odier SCmA owned about 0.13% of Nukkleus at the end of the most recent reporting period. 12.47% of the stock is owned by institutional investors and hedge funds.

Nukkleus Company Profile

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.

Read More

Should You Invest $1,000 in Nukkleus Right Now?

Before you consider Nukkleus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nukkleus wasn't on the list.

While Nukkleus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines